Total neoadjuvant therapy with FOLFOX plus bevacizumab and short-course radiotherapy for Ras mutant, high-risk, locally advanced rectal cancer: The TRAINER trial. Phase Ib study of gevokizumab (GEVO) ...

sunitinib as first-line (1L) treatment for advanced grade 2 (G2) pancreatic neuroendocrine tumors (pNETs). This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...

Diagnosis was confirmed through endoscopic ultrasonography and abdominal CT ... Gastric submucosal tumors were categorized as benign or malignant based on origin and histology, including stromal ...

9 Imaging studies such as computed tomography (CT) or magnetic resonance imaging ... Type-1 grade 2 multi-focal gastric neuroendocrine tumors secondary to chronic autoimmune gastritis.

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published today in Radiology. The findings of ... of lung tumors on CT scans is critical ...

Dr Calais and colleagues described PSMA-PET/CT findings from 182 patients enrolled in 4 prospective studies. The patients had high-risk hormone-sensitive prostate cancer without evidence of ...

A 22-year-old Derby rider was thrown off her horse, prompting a medical evaluation. During testing, doctors discovered a nine-inch tumor in her abdomen and eventual ovarian cancer diagnosis. Ovarian ...

Cabometyx is under clinical development by Exelixis and currently in Phase II for Gastric Cancer ... castration-resistant prostate cancer (MCRPC), neuroendocrine gastroenteropancreatic tumors (GEP-NET ...